BSE-listed · Mumbai
Precision in Formulations. Power in Global Export.
An established listed company building a pharmaceutical platform — bringing manufacture, active ingredients, exports and contract research together under one parent, with capital, governance and international market access held at the centre.
Incorporated 1980 · BSE scrip 539519 · ISIN INE280E01038
What we are
An established business, building a platform.
Tavexia Lifecare Limited is a public company listed on BSE Limited, with an established trading and distribution business. Alongside it, the Company is building a pharmaceutical platform — supplying capital, governance and access to international markets, while the businesses beneath it supply manufacturing, products and customer relationships.
The platform is being assembled by acquisition as well as by organic development. Each business brought into the group keeps its own name, its own management and its own regulatory approvals — because a licence, a certification and a market registration take years to earn, which is exactly what makes them worth owning.
Group structure
Five lines under one parent.
Each line stands on its own commercially. Together they cover research, development, manufacture, supply and route to market.
Manufacturing and CDMO
Contract development and manufacture across oral solid, oral liquid and external preparations, operated to cGMP standards by the group's manufacturing arm.
API marketing and distribution
Sourcing and supply of active pharmaceutical ingredients to formulators in India and overseas.
International exports
Finished formulations and APIs into regulated and semi-regulated markets, with registrations held at group level wherever the territory permits.
Nutraceuticals and consumer health
Nutraceuticals, biotechnology products and allied lines — a portfolio that carries its own margin profile and its own regulatory route.
Clinical research and BA/BE
The group's next line: a bioavailability and bioequivalence centre with contract research, site management, bioanalytical and regulatory support around it.
What the parent contributes
Three things the structure is for.
Capital allocation
Directing capital to the businesses and registrations that earn the best return, rather than to whichever unit shouts loudest.
Listed-standard governance
Board oversight, arm's-length treatment of related parties and continuous disclosure under SEBI LODR and the Companies Act, applied across every business.
Market access
Holding marketing authorisations and acting as local representative where markets require it, so market access stays inside the group.
Where the group operates
Built for the markets that need supply.
The CIS Region
One EAEU dossier now carries across all five member states under a single procedure.
Regulatory pathway →Southeast Asia
A single ACTD structure serves Vietnam and its neighbouring markets.
Regulatory pathway →West Africa
Ghana and Nigeria both hold WHO Maturity Level 3 designation.
Regulatory pathway →Investors and partners
Start a conversation.
For shareholder queries, international procurement, regulatory partnerships, or to request our latest product catalog.
- Telephone
- +91-22-2868 4491
- info@tavexia.com
- Head office
- Mumbai, India
Common questions
The company, in plain terms.
Is Tavexia Lifecare Limited the same company as Sattva Sukun Lifecare Limited?
Yes. The name changed to Tavexia Lifecare Limited on 14 August 2026. It is the same legal entity, with the same CIN, the same BSE scrip code and the same ISIN. The Company was earlier known as Mayukh Dealtrade Limited.
Under what code does the Company trade?
BSE scrip code 539519, ISIN INE280E01038. The Company is listed on BSE Limited and its CIN is L51219MH1980PLC329224.
What does the Company do?
It is an established lifecare business building a pharmaceutical platform, across active pharmaceutical ingredient marketing and export, contract development and manufacturing, research and product development, herbal and nutraceutical products, and clinical research including bioavailability and bioequivalence studies.
Where is the registered office?
Office No. 101, 1st Floor, Crystal Rose CHS Ltd., Datta Mandir Road, Mahavir Nagar, Kandivali (West), Mumbai 400067, Maharashtra, India.
Where are regulatory disclosures published?
On this website, under Investors, and with BSE Limited. Filings made to the exchange prevail in the event of any discrepancy.